» Articles » PMID: 25519995

Analytical Reduction of Combinatorial Complexity Arising from Multiple Protein Modification Sites

Overview
Date 2014 Dec 19
PMID 25519995
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Combinatorial complexity is a major obstacle to ordinary differential equation (ODE) modelling of biochemical networks. For example, a protein with 10 sites that can each be unphosphorylated, phosphorylated or bound to adaptor protein requires 3(10) ODEs. This problem is often dealt with by making ad hoc assumptions which have unclear validity and disallow modelling of site-specific dynamics. Such site-specific dynamics, however, are important in many biological systems. We show here that for a common biological situation where adaptors bind modified sites, binding is slow relative to modification/demodification, and binding to one modified site hinders binding to other sites, for a protein with n modification sites and m adaptor proteins the number of ODEs needed to simulate the site-specific dynamics of biologically relevant, lumped bound adaptor states is independent of the number of modification sites and equal to m + 1, giving a significant reduction in system size. These considerations can be relaxed considerably while retaining reasonably accurate descriptions of the true system dynamics. We apply the theory to model, using only 11 ODEs, the dynamics of ligand-induced phosphorylation of nine tyrosines on epidermal growth factor receptor (EGFR) and primary recruitment of six signalling proteins (Grb2, PI3K, PLCγ1, SHP2, RasA1 and Shc1). The model quantitatively accounts for experimentally determined site-specific phosphorylation and dephosphorylation rates, differential affinities of binding proteins for the phosphorylated sites and binding protein expression levels. Analysis suggests that local concentration of site-specific phosphatases such as SHP2 in membrane subdomains by a factor of approximately 10(7) is critical for effective site-specific regulation. We further show how our framework can be extended with minimal effort to consider binding cooperativity between Grb2 and c-Cbl, which is important for receptor trafficking. Our theory has potentially broad application to reduce combinatorial complexity and allow practical simulation of a variety ODE models relevant to systems biology and pharmacology applications to allow exploration of key aspects of complexity that control signal flux.

Citing Articles

Connectivity of Parameter Regions of Multistationarity for Multisite Phosphorylation Networks.

Kaihnsa N, Telek M Bull Math Biol. 2024; 86(12):144.

PMID: 39495318 PMC: 11534856. DOI: 10.1007/s11538-024-01368-z.


MCell4 with BioNetGen: A Monte Carlo simulator of rule-based reaction-diffusion systems with Python interface.

Husar A, Ordyan M, Garcia G, Yancey J, Saglam A, Faeder J PLoS Comput Biol. 2024; 20(4):e1011800.

PMID: 38656994 PMC: 11073787. DOI: 10.1371/journal.pcbi.1011800.


Assessing complexity and dynamics in epidemics: geographical barriers and facilitators of foot-and-mouth disease dissemination.

Hoogesteyn A, Rivas A, Smith S, Fasina F, Fair J, Kosoy M Front Vet Sci. 2023; 10:1149460.

PMID: 37252396 PMC: 10213354. DOI: 10.3389/fvets.2023.1149460.


Novel insights into sarcomere regulatory systems control of cardiac thin filament activation.

Solis C, Solaro R J Gen Physiol. 2021; 153(7).

PMID: 33740037 PMC: 7988513. DOI: 10.1085/jgp.202012777.


New analysis pipeline for high-throughput domain-peptide affinity experiments improves SH2 interaction data.

Ronan T, Garnett R, Naegle K J Biol Chem. 2020; 295(32):11346-11363.

PMID: 32540967 PMC: 7415975. DOI: 10.1074/jbc.RA120.012503.


References
1.
Fan Y, Wong L, Johnson G . EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity. Biochem J. 2005; 392(Pt 3):417-23. PMC: 1316279. DOI: 10.1042/BJ20051122. View

2.
Brignola P, Lackey K, Kadwell S, Hoffman C, Horne E, Carter H . Comparison of the biochemical and kinetic properties of the type 1 receptor tyrosine kinase intracellular domains. Demonstration of differential sensitivity to kinase inhibitors. J Biol Chem. 2001; 277(2):1576-85. DOI: 10.1074/jbc.M105907200. View

3.
Birtwistle M, Hatakeyama M, Yumoto N, Ogunnaike B, Hoek J, Kholodenko B . Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol Syst Biol. 2007; 3:144. PMC: 2132449. DOI: 10.1038/msb4100188. View

4.
Lemmon M, Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell. 2010; 141(7):1117-34. PMC: 2914105. DOI: 10.1016/j.cell.2010.06.011. View

5.
Peters G, Branner S, Moller K, Andersen J, Moller N . Enzyme kinetic characterization of protein tyrosine phosphatases. Biochimie. 2003; 85(5):527-34. DOI: 10.1016/s0300-9084(03)00036-1. View